Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S B New (OP:NONOF)

49.25 -0.71 (-1.43%)
Streaming Delayed Price Updated: 2:06 PM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novo Nordisk A/S B New

News headline image
Novo Nordisk's Wegovy Demonstrates Greater Weight Loss In Women With Heart Condition ↗
The greater weight loss in women did not result in significantly better improvements in heart failure symptoms. 
Via Benzinga
News headline image
Move Aside Ozempic, WeGovy: Denmark's New Drug Just Showed Positive Results For Weightloss ↗
As per the official press release, the 16-week trial aimed to evaluate the safety, tolerability, and clinical effects of the drug called petrelintide. 
Via Benzinga
News headline image
The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash ↗
Dividend stocks have a record of stability and growth. Read here about three picks that are thriving and hiking dividends amid uncertainty. 
Via InvestorPlace
News headline image
Novo Nordisk's Wegovy Delivers: Long-Term Study Shows Sustained Weight Loss As Drugmaker Tries To Woo Insurers And Governments ↗
The data could potentially bolster Novo's case for Wegovy as it attempts to convince insurers and governments to cover the cost of the drug. 
Via Benzinga
News headline image
7 Mutual Funds That Will Outperform in Any Market ↗
While we’d all love to think we’re market geniuses, we could use the active management of outperforming mutual funds. 
Via InvestorPlace
News headline image
Did Ozempic Play A Role In A Man's Suicide? Family Seeks Warning Label ↗
 
Via Benzinga
News headline image
Emmanuel Macron To Unveil Novo Nordisk Record $2.3B Investment In France's Health Sector ↗
This initiative has been touted as the biggest investment in the health sector ever made during Macron's tenure. 
Via Benzinga
News headline image
Experts Weigh In On Ozempic's Evolving Side Effects And How To Handle Them ↗
 
Via Benzinga
News headline image
Diabetes Drug Ozempic May Hold Key to Breaking Addictions: The Guardian ↗
 
Via Benzinga
News headline image
Icannex Taps Ex Pfizer, FDA & Regulatory Affairs Expert ↗
Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) appointed pharmaceutical executive Robert B. Clark to the board of directors. 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.